Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 efficacy study of quadrivalent seasonal influenza vaccine in healthy children aged 3 to 8 years
2015-001514-97Phase 3
- Sponsor
- GSK
- Start
- May 2015
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of influenza virus quadrivalent inactivated vaccine in influenza (2 arms), sponsored by GSK.
02
Drugs
influenza virus quadrivalent inactivated vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2015-001514-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001514-97.